Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 70
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Single-cell profiling reveals a conserved role for hypoxia-inducible factor signaling during human craniotomy infection

Single-cell profiling reveals a conserved role for hypo...

 87

AI-driven fusion of multimodal data for Alzheimer’s disease biomarker assessment

AI-driven fusion of multimodal data for Alzheimer’s dis...

 74

How control modulates pain

How control modulates pain

 87